Diabetes mellitus mitigates cardioprotective effects of remifentanil preconditioning in ischemia-reperfused rat heart in association with anti-apoptotic pathways of survival

Pharmacology, Toxicology and Pharmaceutical Science

• Diabetes Mellitus 90%
• Ischemia 90%
• Remifentanil 90%
• Antiapoptotic 80%
• Rat 70%
• Mitogen Activated Protein Kinase 3 40%
• Wild Type Rat 30%
• Protein 20%
• Calcium Ion 20%
• Cytochrome C 20%
• Heart Infarction 20%
• Survival 20%
• Reperfusion Injury 10%
• Sprague Dawley Rat 10%
• Opiate 10%
• Protein Bax 10%
• Streptozotocin 10%
• Protein Bcl 2 10%
• Coronary Artery Occlusion 10%

Medicine and Dentistry

• Ischemia 90%
• Remifentanil 90%
• Diabetes Mellitus 60%
• Heart 50%
• Mitogen Activated Protein Kinase 3 40%
• Homeostasis 20%
• Protein 20%
• Myocardial Infarction 20%
• Calcium Ion 20%
• Cytochrome C 20%
• Sarcoplasmic reticulum 20%
• Heart Protection 20%
• Gene 20%
• Survival 20%
• Phosphorylation 10%
• Gene Expression 10%
• Reperfusion Injury 10%
• Opiate 10%
• Streptozocin 10%
• Protein Bcl 2 10%
• Age 10%
• Protein Bax 10%
• Coronary Occlusion 10%
• Left Anterior Descending Coronary Artery 10%
• Cardiac Anesthesia 10%
• Association 10%

Neuroscience

• Ischemia 100%
• Remifentanil 90%
• Cardiovascular System 50%
• Mitogen Activated Protein Kinase 3 40%
• Diabetes 30%
• Cytochrome C 20%
• Diabetes Mellitus 20%
• Gene 20%
• Protein 20%
• Sarcoplasmic Reticulum 20%
• Phosphorylation 10%
• Gene Expression 10%
• Reperfusion Injury 10%
• Protein Bcl 2 10%
• Streptozotocin 10%
• Opioid 10%
• Bcl-2-Associated X Protein 10%